braun getty

2013 Preview: Why Ryan Braun, Alex Rodriguez and other big stars could face suspension this season

70 Comments

As we approach Opening Day, HarballTalk will be spending the next few days previewing all 30 teams, all six division races and looking ahead at the major issues and storylines which will impact the 2013 season. This morning we look at the Biogenesis scandal, which could lead to the suspension of several high-profile players.

Some of baseball’s biggest stars including Ryan Braun, Alex Rodriguez, Nelson Cruz, Gio Gonzalez, Yasmani Grandal, Bartolo Colon and many, many more enter the 2013 season under a cloud. Or a threat, if you will.  The threat of suspension for their association with a now-closed Miami clinic called Biogenesis, which is alleged to have supplied these players and as many as 90 more with testosterone, human growth hormone and other performance enhancing drugs which violate baseball’s rules against performance enhancing drugs. It is unknown if those suspensions will come. It is unknown when. But all teams with a player named in the documents of the Biogenesis clinic face uncertainty as Opening Day approaches.

The Biogenesis news broke in late January, when it was reported by multiple outlets that Major League Baseball was investigating the clinic and its operator, Anthony Bosch, under the suspicion that the clinic represented “ground zero” for performance enhancing drugs in Florida, where a disproportionate number of major leaguers grew up, played amateur and college baseball or where they currently make their offseason homes. On January 29, the Miami New Times obtained and published a large portion of the Biogenesis clinic’s records which contained the names of several major leaguers accompanied in many cases by notations which suggested that the players were given performance enhancing drugs. The documents were not conclusive of any player’s use and, in some cases — like with Nationals pitcher Gio Gonzalez — no connection could be found between the player and any substances which are banned by Major League Baseball.

source: APImmediately after the Miami New Times report came out all of the players involved either denied any involvement with Biogenesis whatsoever or denied that they obtained banned substances.  For example, Gonzalez claims that his father was a patient of Anthony Bosch’s. Ryan Braun claims that his attorneys used Bosch as a consultant in his successful 2012 appeal of his PED suspension. Despite the denials, the report and the documents set off a media firestorm which caused Major League Baseball to step up its investigation of the players named therein.

The biggest problem: Major League Baseball doesn’t actually have the Biogenesis documents. The Miami New Times and other media outlets which have seen all or part of them are unwilling to share them with the league and, at present, Anthony Bosch is nowhere to be found.  Last Friday Major League Baseball sued Biogenesis in an effort to obtain the documents, but it is not at all clear that they have any viable legal claims against the clinic. More significantly, many doubt that the original documents still exist at all.

What is clear is that Major League Baseball is stopping at nothing to investigate the matter with a clear eye towards suspending the players named in the clinic’s records if at all possible.  MLB is reported to be particularly interested in suspending 2011 NL MVP Braun, who they see as having evaded justice in prevailing on his appeal last year and Rodriguez who many in baseball believe lied to MLB investigators in 2009 when he admitted to past, but not present drug use.

MORE: The Rise and Fall of Alex Rodriguez

source: APCan Major League Baseball suspend these players without a positive drug test? Yes, it can. Pursuant to the Joint Drug Agreement which governs these matters, baseball can suspend players for “just cause” if there is non-clinical evidence suggesting that they have used performance enhancing drugs. Most believe that conclusive documentary evidence of past use, as may appear in the Biogenesis records, would provide such grounds. Baseball’s inability to obtain these records, however, is preventing almost all action at present. So far, all baseball has been able to do is to suspend one minor leaguer  — who happens to have been a college teammate and who is still a close friend of Braun’s — who was implicated based on the league’s belief that he was not cooperative when questioned. Major league players have not yet been questioned, but they almost certainly will be.  They will have greater legal and union protections from discipline than their minor league counterparts, however.

That’s where we are as the season dawns. Several players, including two former MVPs, in the crosshairs of a Major League Baseball investigation, the outcome of which and endpoint of is uncertain. At literally any time between today and, well, forever, baseball could suspend Braun, Rodriguez, Gonzalez, Cruz or any of players named in the Biogenesis documents for 50 games.

To put that in context, the most big leaguers Major League Baseball has ever suspended in a season for performance enhancing drugs is six, which occurred last year.  In most years it’s two or three.  Now dozens upon dozens of players may face a 50-game suspension for a first offense of the Joint Drug Agreement, with some facing 100-game suspensions for a second offense. Suspensions of this magnitude could conceivably tip the pennant races. And for that reason, even if you don’t care a lick about performance enhancing drugs in baseball, the Biogenesis matter is worth watching.

MORE: Team-by-team previews for 2013

Colin Rea loses no-hit bid in the seventh against the Mets

San Diego Padres starting pitcher Colin Rea works against a Pittsburgh Pirates batter during the first inning of a baseball game Tuesday, April 19, 2016, in San Diego. (AP Photo/Gregory Bull)
AP Photo/Gregory Bull
Leave a comment

Update (12:01 AM EDT): And it’s over. Yoenis Cespedes drove a ground ball single to right field with two outs in the seventh inning to end Rea’s no-hit bid.

*

Padres starter Colin Rea has tamed the hot-hitting Mets lineup so far this Thursday night. The right-hander has walked only one, the lone batter above the minimum he has faced. Rea has also struck out three while accumulating 76 pitches.

The Padres’ offense provided Rea with five runs of support, scoring once in each of the first, second, and third, as well as twice in the sixth. Wil Myers smacked a solo homer off of Jacob deGrom in the first inning. Rea helped himself with an RBI single in the second, Alexei Ramirez brought in a run with a double in the third, Derek Norris drove a solo homer in the sixth, and Jon Jay shortly thereafter hit an RBI double.

The Mets entered play Thursday tied for the National League lead in home runs hit as a team with 40. Rea, meanwhile, came into Thursday’s action with a 4.61 ERA and a 22/13 K/BB ratio in 27 1/3 innings spanning five starts and one relief appearance.

If Rea is able to complete the job, he would become the first pitcher in Padres history to throw a no-hitter. Jake Arrieta threw the first no-hitter of the 2016 season on April 21 against the Reds.

We’ll keep you updated as Rea attempts to navigate through the final three innings.

Jason Heyward hopes to return to Cubs’ lineup on Friday

Chicago Cubs' Jason Heyward hits a double to drive in Dexter Fowler off Cincinnati Reds relief pitcher J.J. Hoover during the ninth inning of a baseball game, Friday, April 22, 2016, in Cincinnati. The Cubs won 8-1. (AP Photo/John Minchillo)
AP Photo/John Minchillo
1 Comment

Cubs outfielder Jason Heyward hasn’t played since Sunday due to a sore right wrist, but he’s hoping to be included in his team’s lineup on Friday, MLB.com’s Carrie Muskat reports. Matt Szucur, Ben Zobrist, and Kris Bryant have handled right field while Heyward has been out.

Heyward, 26, has gotten off to a disappointing start, as he’s batting .211/.317/.256 with only four doubles, no home runs, and 13 RBI in 104 plate appearances. He signed an eight-year, $184 million contract with the Cubs back in December.

Heyward said he hurt his wrist putting emphasis on it during hitting drills. He said, “I was doing some work off the tee and doing a drill with a donut on the bat, swinging, trying to stay through the middle, and I put more emphasis on [his wrist] and strained it from that.”

Cardinals plan to get creative to keep Aledmys Diaz in the lineup

St. Louis Cardinals' Jedd Gyorko high-fives with Matt Carpenter as they and Aledmys Diaz, center, leave the field following the Cardinals' 11-2 victory over the San Diego Padres in a baseball game Saturday, April 23, 2016, in San Diego. (AP Photo/Lenny Ignelzi)
AP Photo/Lenny Ignelzi
2 Comments

Cardinals shortstop Jhonny Peralta is expected to return from the disabled list in early June, which means current shortstop Aledmys Diaz would return to the bench. There’s only one problem: Diaz has been one of the best hitters in baseball. The 25-year-old owns a sparkling .381/.422/.679 triple-slash line with 14 extra-base hits (including five homers) in 90 plate appearances.

The Cardinals plan to get creative to keep Diaz’s bat in the lineup. Per Jon Morosi of FOX Sports, the club is considering using Peralta at first and third base. Peralta, 33, last played third base in 2010 with the Indians and Tigers. He has logged only three games and nine total defensive innings at first base in his major league career.

Diaz isn’t about to displace Peralta. Last season, Peralta was one of the best-hitting shortstops, finishing with a .275/.334/.411 triple-slash line with 17 home runs and 41 RBI in 640 plate appearances. He was even more productive in 2014, his first year with the Cardinals.

Chris Bassitt will undergo Tommy John surgery on Friday

Oakland Athletics pitcher Chris Bassitt sits in the dugout after being relieved against the Detroit Tigers in the fourth inning of a baseball game in Detroit, Thursday, April 28, 2016. (AP Photo/Paul Sancya)
AP Photo/Paul Sancya
Leave a comment

Athletics pitcher Chris Bassitt will undergo season-ending Tommy John surgery on Friday, MLB.com’s Jane Lee reports. He was diagnosed with a partially torn ulnar collateral ligament over the weekend, so this news doesn’t come as much of a surprise.

Bassitt, 27, is certainly out for the remainder of the 2016 season and will likely miss a sizable portion of the 2017 season as well. The right-hander made five starts for the A’s to begin the season, but put up an ugly 6.11 ERA with a 23/14 K/BB ratio in 28 innings.

Jesse Hahn took Bassitt’s spot in the Athletics’ starting rotation. Hahn is expected to start next on Saturday versus the Orioles.